Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

BREAK THROUGH CANCER — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Termination (No Activity)

BREAK THROUGH CANCER

via THE FEDERAL GROUP, INC.

2nd Quarter (Apr 1 - June 30) · 2024Posted Aug 8, 2024Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: BREAK THROUGH CANCER
Description: A collaborative medical research organization
Location: Massachusetts · United States of America

Registrant

Firm: THE FEDERAL GROUP, INC.
Description: Federal government relations consulting
Location: Alexandria, Virginia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.